4.7 Article Proceedings Paper

Modeling peptide fragmentation with dynamic Bayesian networks for peptide identification

期刊

BIOINFORMATICS
卷 24, 期 13, 页码 I348-I356

出版社

OXFORD UNIV PRESS
DOI: 10.1093/bioinformatics/btn189

关键词

-

资金

  1. NCRR NIH HHS [P41 RR011823-13, P41 RR11823, P41 RR011823] Funding Source: Medline
  2. NIBIB NIH HHS [R01 EB007057, R01 EB007057-02] Funding Source: Medline
  3. NIGMS NIH HHS [P41 GM103533] Funding Source: Medline

向作者/读者索取更多资源

Motivation: Tandem mass spectrometry (MS/MS) is an indispensable technology for identification of proteins from complex mixtures. Proteins are digested to peptides that are then identified by their fragmentation patterns in the mass spectrometer. Thus, at its core, MS/MS protein identification relies on the relative predictability of peptide fragmentation. Unfortunately, peptide fragmentation is complex and not fully understood, and what is understood is not always exploited by peptide identification algorithms. Results: We use a hybrid dynamic Bayesian network (DBN)/support vector machine (SVM) approach to address these two problems. We train a set of DBNs on high-confidence peptide-spectrum matches. These DBNs, known collectively as Riptide, comprise a probabilistic model of peptide fragmentation chemistry. Examination of the distributions learned by Riptide allows identification of new trends, such as prevalent a-ion fragmentation at peptide cleavage sites C-term to hydrophobic residues. In addition, Riptide can be used to produce likelihood scores that indicate whether a given peptide-spectrum match is correct. A vector of such scores is evaluated by an SVM, which produces a final score to be used in peptide identification. Using Riptide in this way yields improved discrimination when compared to other state-of-the-art MS/MS identification algorithms, increasing the number of positive identifications by as much as 12% at a 1% false discovery rate.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据